NUVL
NUVL
NASDAQ · Biotechnology

Nuvalent Inc-A

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$98.00
+1.85 (+1.92%)
As of Mar 25, 9:48 PM ET ·
Analyst Consensus
Strong Buy
24
Analysts
High
Coverage
Buy 23 96%
Hold 1 4%
Sell 0 0%
Price Target
Analyst Price Target -66.0% upside
Low Target $20.12
Average Target $33.28
High Target $44.46
Current Price $98.00
Current
$98.00
Target
$33.28
$20.12 $33.28 avg $44.46
Scenario Analysis
Bear Case
$20.12
-79.5%
Low target
Base Case
$33.28
-66.0%
Avg target
Bull Case
$44.46
+-54.6%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$113.02
-13.3% from high
52-Week Low
$55.54
+76.5% from low
50-Day SMA
$103.76
-5.6% vs SMA
200-Day SMA
$88.57
+10.6% vs SMA
RSI (14)
53.7
Neutral
Target vs 52W High
$33.28
-70.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -27.6%